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This data article contains complementary figures related to the
research article entitled, “Transforming growth factor-β-induced
CUX1 isoforms are associated with fibrosis in systemic sclerosis
lung fibroblasts” (Ikeda et al. (2016) [2], http://dx.doi.org/10.1016/j.
bbrep.2016.06.022), which presents that TGF-β increased CUX1
binding in the proximal promoter and enhancer of the COL1A2 and
regulated COL1. Further, in the scleroderma (SSc) lung and diffuse
alveolar damage lung sections, CUX1 localized within the α-
smooth muscle actin (α-SMA) positive cells (Fragiadaki et al., 2011)
[1], “High doses of TGF-beta potently suppress type I collagen via
the transcription factor CUX1” (Ikeda et al., 2016) [2]. Here we
show that CUX1 isoforms are localized within α-smooth muscle
actin-positive cells in SSc skin and idiopathic pulmonary fibrosis
(IPF) lung tissue sections. In particular, at the granular and prickle
cell layers in the SSc skin sections, CUX1 and α-SMA are co-
localized. In addition, at the fibrotic loci in the IPF lung tissue
sections, CUX1 localized within the α-smooth muscle actin (α-
SMA) positive cells.vier Inc. This is an open access article under the CC BY license
/j.bbrep.2016.06.022
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acquiredConfocal microscopy (Zeiss Axioscope light microscope, Carl Zeiss)ata format Analysed
xperimental
factorsFor immunohistochemistry, sections were pretreated with methanol, fol-
lowed by antigen retrieval in heated 10-mM citrate buffer (pH 6).xperimental
featuresThe primary antibodies were CUX1 antibody (0.2 mg/ml) and the mono-
clonal anti-α-SMA clone, 1a Cy3-conjugated antibody (0.7 mg/ml). Sections
were sequentially incubated with a 1/200 dilution of an Alexa 488 secondary
antibody.ata source
locationLondon, United Kingdomata accessibility Data presented in this articleD
Value of the data
 The data provides the evidence that CUX1 isoforms localise within α-smooth muscle actin-positive
cells in SSc skin tissue sections, especially in the granular and prickle cell layers.
 The data provides the evidence that CUX1 isoforms localise within α-smooth muscle actin-positive
cells at the fibrotic loci in idiopathic pulmonary fibrosis (IPF) lung tissue sections.
 The data could further help research on the function of CUX1 isoforms in fibrosis-related diseases.1. Data
Immunohistochemistry revealed the presence of α-SMA-positive fibrotic loci, which are char-
acteristic in the lungs of patients with IPF and in the skin of patients with SSc. In the IPF tissue
sections, CUX1 localised at alveolar cells and fibrotic loci. In addition, CUX1 localised within α-SMA-
positive cells but was not observed in the normal lung section (Fig. 1). In the SSc skin tissue sections,
CUX1 co‐localised with α-SMA at the granular cell layer, prickle cell layer and fibrotic loci in the
epidermis. In addition, CUX1 localised within α-SMA-positive cells. These were not observed at the
epidermis in the normal skin sections (Fig. 2).2. Experimental design, materials and methods
For formalin-fixed, paraffin-embedded specimens, the tissues were fixed and hydrated as
described previously [1,2]. For immunohistochemistry, the sections were pretreated with methanol
(VWR, Lutterworth, UK), followed by antigen retrieval in heated 10-mM citrate buffer (pH 6). The
primary antibodies were CUX1 antibody (0.2 mg/ml) and the monoclonal anti-α-SMA clone, 1a Cy3-
conjugated antibody (0.7 mg/ml). The sections were sequentially incubated with a 1/200 dilution of
Fig. 2. Systemic sclerosis (SSc) skin tissue sections stained with antibodies against CUX1 and α-smooth muscle actin (SMA).
The figure shows epidermis that were stained by CUX1 and α-SMA antibodies. The granular and prickle cells in the epidermis
were positive for CUX1 and α-SMA. CUX1 localised within α-SMA-positive cells. Normal skin sections were used as negative
control for CUX1 and α-SMA.
Fig. 1. Idiopathic pulmonary fibrosis (IPF) lung tissue sections stained with antibodies against CUX1 and α-smooth muscle
actin (SMA). The figure shows fibrotic loci that were stained by CUX1 and α-SMA antibodies. Alveolar cells around the loci were
positive for CUX1 and α-SMA. CUX1 localised within α-SMA-positive cells. Normal lung sections were used as negative control
for CUX1 and α-SMA.
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light microscope with Axiovision software.Acknowledgments
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